These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19768417)

  • 1. Immunosenescence and influenza vaccine efficacy.
    Sambhara S; McElhaney JE
    Curr Top Microbiol Immunol; 2009; 333():413-29. PubMed ID: 19768417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving immunogenicity and effectiveness of influenza vaccine in older adults.
    Cao W; Kim JH; Chirkova T; Reber AJ; Biber R; Shay DK; Sambhara S
    Expert Rev Vaccines; 2011 Nov; 10(11):1529-37. PubMed ID: 22043953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal influenza immunisation: Strategies for older adults.
    Schaffner W; van Buynder P; McNeil S; Osterhaus ADME
    Int J Clin Pract; 2018 Oct; 72(10):e13249. PubMed ID: 30216647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.
    Wagner A; Weinberger B
    Front Immunol; 2020; 11():717. PubMed ID: 32391017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.
    van den Berg SPH; Wong A; Hendriks M; Jacobi RHJ; van Baarle D; van Beek J
    Front Immunol; 2018; 9():82. PubMed ID: 29434600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging and impaired immunity to influenza viruses: implications for vaccine development.
    Liu WM; van der Zeijst BA; Boog CJ; Soethout EC
    Hum Vaccin; 2011; 7 Suppl():94-8. PubMed ID: 21301210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responders and non-responders to influenza vaccination: A DNA methylation approach on blood cells.
    Gensous N; Franceschi C; Blomberg BB; Pirazzini C; Ravaioli F; Gentilini D; Di Blasio AM; Garagnani P; Frasca D; Bacalini MG
    Exp Gerontol; 2018 May; 105():94-100. PubMed ID: 29360511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.
    Avey S; Mohanty S; Chawla DG; Meng H; Bandaranayake T; Ueda I; Zapata HJ; Park K; Blevins TP; Tsang S; Belshe RB; Kaech SM; Shaw AC; Kleinstein SH
    J Immunol; 2020 Mar; 204(6):1661-1673. PubMed ID: 32060136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and influenza vaccine-induced immunity.
    Dugan HL; Henry C; Wilson PC
    Cell Immunol; 2020 Feb; 348():103998. PubMed ID: 31733824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine responsiveness in the elderly: best practice for the clinic.
    Aspinall R; Lang PO
    Expert Rev Vaccines; 2014 Jul; 13(7):885-94. PubMed ID: 24890875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosenescence of the equine immune system.
    Horohov DW; Adams AA; Chambers TM
    J Comp Pathol; 2010 Jan; 142 Suppl 1():S78-84. PubMed ID: 19897209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine responses in older adults.
    McElhaney JE
    Ageing Res Rev; 2011 Jul; 10(3):379-88. PubMed ID: 21055484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations in responses to vaccines in older people].
    Autran B
    Rev Mal Respir; 2019 Nov; 36(9):1047-1056. PubMed ID: 31522947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice.
    Wen Z; Wang X; Dong K; Zhang H; Bu Z; Ye L; Yang C
    Microbes Infect; 2017 Dec; 19(12):626-634. PubMed ID: 28899815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.
    Merani S; Kuchel GA; Kleppinger A; McElhaney JE
    Exp Gerontol; 2018 Jul; 107():116-125. PubMed ID: 28958701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults.
    Bartley JM; Cadar AN; Martin DE
    Immunol Invest; 2021 Oct; 50(7):810-820. PubMed ID: 33830864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
    Nunzi E; Iorio AM; Camilloni B
    Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population.
    Lee BY; Ercius AK; Smith KJ
    Vaccine; 2009 Apr; 27(16):2251-7. PubMed ID: 19428839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.